Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Dow Jones Turns Lower; Revlon Shares Jump

U.S. stocks pared gains midway through trading, with the Dow Jones dropping around 100 points on Friday.

Benzinga

33 Stocks Moving In Friday's Mid-Day Session

Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.

Benzinga

What 11 Analyst Ratings Have To Say About Hub Group

Within the last quarter, Hub Group (NASDAQ:HUBG) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Expert Ratings for KLA

Analysts have provided the following ratings for KLA (NASDAQ:KLAC) within the last quarter:

Benzinga

Where Peloton Interactive Stands With Analysts

Peloton Interactive (NASDAQ:PTON) has observed the following analyst ratings within the last quarter:

Benzinga

Here's How Much $1000 Invested In Texas Instruments 20 Years Ago Would Be Worth Today

Texas Instruments (NASDAQ:TXN) has outperformed the market over the past 20 years by 2.92% on an annualized basis producing an average annual return of 9.75%. Currently, Texas Instruments has a market capitalization of $138.82 billion.

Benzinga

Expert Ratings for Fifth Third Bancorp

Analysts have provided the following ratings for Fifth Third Bancorp (NASDAQ:FITB) within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Keybanc Maintains Overweight Rating for KLA: Here's What You Need To Know

Keybanc has decided to maintain its Overweight rating of KLA (NASDAQ:KLAC) and lower its price target from $440.00 to $375.00. Shares of KLA are trading down 0.13% over the last 24 hours, at $310.00 per share. A move to $375.00 would account for a 20.97% increase from the current share…

Benzinga

Piper Sandler Maintains Overweight Rating for Equity Bancshares: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Equity Bancshares (NASDAQ:EQBK) and lower its price target from $38.00 to $35.00. Shares of Equity Bancshares are trading up 1.65% over the last 24 hours, at $30.79 per share.

Benzinga

Short Volatility Alert: Ebix, Inc.

On Thursday, shares of Ebix, Inc. (NASDAQ: EBIX) experienced volatile short activity. After the activity, the stock price went down -37.65% to $14.59. The overall sentiment for EBIX has been Neutral.

Benzinga

Short Volatility Alert: Legend Biotech Corporation

On Thursday, shares of Legend Biotech Corporation (NASDAQ: LEGN) experienced volatile short activity. After the activity, the stock price went down -1.38% to $42.96. The overall sentiment for LEGN has been Bullish.

Benzinga

Short Volatility Alert: Strategic Education, Inc.

On Thursday, shares of Strategic Education, Inc. (NASDAQ: STRA) experienced volatile short activity. After the activity, the stock price went down -2.77% to $60.00. The overall sentiment for STRA has been Neutral.

Benzinga

Pactiv Evergreen Introduces Tamper Evident Fry Cartons

Pactiv Evergreen Inc (NASDAQ:PTVE) has launched new Tamper Evident Fry Cartons to meet the evolving needs of foodservice operators. Tamper Evident Fry Cartons were designed with portability, safety, and security in mind to cater to the takeout and delivery market. It has a tamper-evident latch that must be torn to access the contents…

Benzinga

Why Scholar Rock Shares Are Trading Higher Today

Scholar Rock Holding Corp (NASDAQ:SRRK) announced new data from the Phase 2 TOPAZ trial extension period evaluating apitegromab in non-ambulatory patients with Types 2 and 3 Spinal Muscular Atrophy (SMA) receiving an SMN therapy. The trial assessed patient outcomes after 24 months of treatment. All 35 non-ambulatory patients (Cohorts 2 and 3) and…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Merck Shows Takeover Interest In Seagen: WSJ

Merck & Co Inc (NYSE:MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens, it would be significant, given Seagen's market value of roughly $28 billion. According to the report, some people said other unnamed suitors are also eying Seagen, a…

Benzinga

5 Analysts Have This to Say About Rhythm Pharmaceuticals

Rhythm Pharmaceuticals (NASDAQ:RYTM) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for Grab Hldgs

Analysts have provided the following ratings for Grab Hldgs (NASDAQ:GRAB) within the last quarter:

Benzinga

WISeKey Forges NFT Collaboration With The China Museum Of Finance

Cybersecurity, AI, Blockchain, and IoT company WISeKey International Holding AG (NASDAQ:WKEY) collaborated with The China Museum of Finance to offer Trusted NFTs with the launch of WISe.ART NFT platform. The WISe.ART NFT Platform is an Ethereum scaling and infrastructure development available with Ethereum-compatible blockchains. The WISe.ART platform will auction a historical NFT of the…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Emmy Awards Producers Approach Chris Rock And Dwayne Johnson For Hosting Duties: Report

An effort is underway to attract Chris Rock and/or Dwayne Johnson as potential hosts of the 74th Primetime Emmy Awards, which will be broadcast on Sept. 12 on NBC, a division of Comcast Corporation (NASDAQ: CMCSA).

Benzinga

Ominous Death Cross Forms On Keurig Dr Pepper's Chart

If history is any guide, there may be trouble ahead for shares of Keurig Dr Pepper (NASDAQ:KDP). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Ominous Death Cross Forms On Costco Wholesale's Chart

If history is any guide, there may be trouble ahead for shares of Costco Wholesale (NASDAQ:COST). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Here's Why Needham Sees Apple's Brand Value Worth At $1T

Needham analyst Laura Martin believes lifetime value (LTV) is the primary driver of upside value for Apple Inc (NASDAQ: AAPL) and that brand value is a leading indicator of LTV in a note titled "AAPL's Brand is Worth $1 Trillion."

Benzinga

Looking At Advanced Micro Devices's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Advanced Micro Devices (NASDAQ:AMD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2022

Upgrades

1 … 399 400 401 402

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.